+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Diabetes Care Devices Market by Device Type, Technology, Delivery Mode, Insulin Type, Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 192 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5311206
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior decision-makers require actionable intelligence to navigate the evolving diabetes care devices market, where rapid advancements in technology and shifting regulatory frameworks are redefining competitive strategies and patient outcomes.

Market Snapshot: Diabetes Care Devices Market Growth and Performance

The Diabetes Care Devices Market grew from USD 3.10 billion in 2024 to USD 3.68 billion in 2025. It is expected to continue growing at a CAGR of 18.64%, reaching USD 8.66 billion by 2030. The sector's robust expansion reflects intensified global demand for advanced monitoring and insulin delivery solutions. This growth is propelled by the rising prevalence of diabetes, increasing patient focus on self-management, and manufacturers' efforts to integrate next-generation technologies within connected healthcare ecosystems. Such factors indicate accelerating adoption curves across both mature and emerging regions.

Scope & Segmentation: Comprehensive Market Coverage

  • Device Types: Artificial pancreas systems (full closed loop, hybrid closed loop), glucose monitoring devices (continuous, flash, self-monitoring), injection aids (infusion sets, pen needles, syringe needles), insulin pens (prefilled disposable, reusable, smart), insulin pumps (patch, tubed), and insulin syringes.
  • Technologies: Continuous and flash glucose monitoring (real-time, retrospective), self-monitoring platforms (glucose meters, lancets, test strips).
  • Delivery Modes: Continuous and intermittent insulin administration methods.
  • Insulin Types: Intermediate acting, long acting (detemir, glargine), rapid acting (aspart, glulisine, lispro), short acting, and ultra-long acting formulations.
  • Distribution Channels: Direct sales, hospital pharmacies, online platforms, retail pharmacies (chain and independent).
  • End Users: Diagnostic centers, home care settings, hospitals, general and diabetes-specific clinics.
  • Geographic Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including key markets such as United Kingdom, Germany, France, United Arab Emirates, South Africa), and Asia-Pacific (China, India, Japan, Australia, other regional economies).
  • Key Companies: Abbott Laboratories, Medtronic plc, Roche Holding AG, Dexcom, Inc., Becton, Dickinson and Company, Insulet Corporation, Tandem Diabetes Care, Inc., Terumo Corporation, Kyowa Kirin Co., Ltd., Ypsomed Holding AG.

Key Takeaways: Strategic Insights for Decision-Makers

  • The diabetes care device industry is undergoing rapid transformation, driven by integration of advanced sensor technologies, data analytics, and cloud computing that enable more personalized, patient-centric care models.
  • Continuous glucose monitoring platforms are converging with automated insulin delivery, supporting the development of hybrid and closed loop systems that respond dynamically to real-time patient needs.
  • Manufacturers are investing in miniaturization, wireless communication, and smart device capabilities to enhance usability and drive wider adoption beyond specialist clinical contexts.
  • Regional market penetration relies on a nuanced understanding of diverse regulatory environments, distribution networks, and reimbursement models, especially in the Americas, EMEA, and Asia-Pacific.
  • Strategic collaborations between device manufacturers, digital health solution providers, and healthcare payers are reshaping competitive dynamics and accelerating the rollout of integrated management tools.
  • Cost structures and supply chain resiliency are increasingly influenced by global policy shifts, requiring operational agility and robust stakeholder engagement.

Tariff Impact: Navigating U.S. Policy Shifts in Diabetes Care Device Supply Chains

Recent United States tariffs have imposed higher duties on critical diabetes care device components, particularly those utilizing specialized polymers, sensor wafers, and advanced battery elements. These measures have created upward cost pressure for manufacturers, prompting shifts in sourcing strategies and greater scrutiny of supply chain partners. As a result, industry leaders are diversifying suppliers, assessing tariff-exempt production zones, and engaging with policymakers to secure exemptions for vital medical technologies. Enhanced supply chain transparency and real-time risk analytics are now essential for managing continuity and mitigating cost volatility.

Methodology & Data Sources

This report utilizes a rigorous blend of secondary research—including peer-reviewed journals and regulatory filings—and primary expert interviews with leading industry stakeholders. The analytical framework segments the market by device type, technology, delivery mode, insulin class, distribution route, and end user to ensure actionable insights grounded in validated quantitative and qualitative data.

Why This Report Matters

  • Enables senior leaders to anticipate strategic risks and market entry barriers by providing clear intelligence on technology adoption, regulatory shifts, and regional growth levers within the diabetes care device landscape.
  • Delivers a nuanced segmentation analysis that informs investment, operational planning, and commercial expansion—supporting data-driven decision-making at the executive level.
  • Supplies a timely assessment of supply chain and tariff impacts, equipping stakeholders to respond proactively to global policy dynamics and evolving manufacturer–payer relationships.

Conclusion

The diabetes care devices market is evolving toward data-driven, patient-centered solutions that demand adaptive strategies and informed collaboration. This report delivers the comprehensive insights required for stakeholders to advance innovation, manage operational complexity, and drive sustained growth in a changing marketplace.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of continuous glucose monitoring with AI-powered predictive analytics platforms for proactive glycemic control
5.2. Development of non-invasive glucose monitoring sensors utilizing spectroscopic technologies and microneedle arrays
5.3. Emergence of closed-loop insulin delivery systems combining automated dosing algorithms and personalized data feedback
5.4. Expansion of telehealth-enabled insulin pens with Bluetooth connectivity for remote dose tracking and adherence monitoring
5.5. Investment in multi-parameter wearable biosensors for simultaneous monitoring of glucose, heart rate and activity metrics
5.6. FDA clearance trends for bi-hormonal artificial pancreas prototypes delivering both insulin and glucagon through closed-loop systems
5.7. Adoption of standardized interoperability protocols to integrate CGM data across diverse diabetes management apps and electronic health records
5.8. Growth of patient-centric device designs focusing on wearable comfort and simplified interfaces for elderly and pediatric users
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Diabetes Care Devices Market, by Device Type
8.1. Introduction
8.2. Artificial Pancreas Systems
8.2.1. Full Closed Loop
8.2.2. Hybrid Closed Loop
8.3. Glucose Monitoring Devices
8.3.1. Continuous Glucose Monitoring
8.3.2. Flash Glucose Monitoring
8.3.3. Self Monitoring Blood Glucose
8.4. Injection Aids
8.4.1. Infusion Sets
8.4.2. Pen Needles
8.4.3. Syringe Needles
8.5. Insulin Pens
8.5.1. Prefilled Disposable Pens
8.5.2. Reusable Pens
8.5.3. Smart Pens
8.6. Insulin Pumps
8.6.1. Patch Pumps
8.6.2. Tubed Pumps
8.7. Insulin Syringes
9. Diabetes Care Devices Market, by Technology
9.1. Introduction
9.2. Continuous Glucose Monitoring
9.2.1. Real Time Continuous Glucose Monitoring
9.2.2. Retrospective Continuous Glucose Monitoring
9.3. Flash Glucose Monitoring
9.4. Self Monitoring Blood Glucose
9.4.1. Glucose Meters
9.4.2. Lancets
9.4.3. Test Strips
10. Diabetes Care Devices Market, by Delivery Mode
10.1. Introduction
10.2. Continuous Delivery
10.3. Intermittent Delivery
11. Diabetes Care Devices Market, by Insulin Type
11.1. Introduction
11.2. Intermediate Acting
11.3. Long Acting
11.3.1. Detemir
11.3.2. Glargine
11.4. Rapid Acting
11.4.1. Aspart
11.4.2. Glulisine
11.4.3. Lispro
11.5. Short Acting
11.6. Ultra Long Acting
12. Diabetes Care Devices Market, by Distribution Channel
12.1. Introduction
12.2. Direct Sales
12.3. Hospital Pharmacies
12.4. Online Channels
12.5. Retail Pharmacies
12.5.1. Chain Pharmacies
12.5.2. Independent Pharmacies
13. Diabetes Care Devices Market, by End User
13.1. Introduction
13.2. Diagnostic Centers
13.3. Home Care
13.4. Hospitals And Clinics
13.4.1. Diabetes Clinics
13.4.2. General Clinics
14. Americas Diabetes Care Devices Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Diabetes Care Devices Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Diabetes Care Devices Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Abbott Laboratories
17.3.2. Medtronic plc
17.3.3. Roche Holding AG
17.3.4. Dexcom, Inc.
17.3.5. Becton, Dickinson and Company
17.3.6. Insulet Corporation
17.3.7. Tandem Diabetes Care, Inc.
17.3.8. Terumo Corporation
17.3.9. Kyowa Kirin Co., Ltd.
17.3.10. Ypsomed Holding AG
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. DIABETES CARE DEVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DIABETES CARE DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. DIABETES CARE DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. DIABETES CARE DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. DIABETES CARE DEVICES MARKET: RESEARCHAI
FIGURE 28. DIABETES CARE DEVICES MARKET: RESEARCHSTATISTICS
FIGURE 29. DIABETES CARE DEVICES MARKET: RESEARCHCONTACTS
FIGURE 30. DIABETES CARE DEVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DIABETES CARE DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DIABETES CARE DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DIABETES CARE DEVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY FULL CLOSED LOOP, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY FULL CLOSED LOOP, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HYBRID CLOSED LOOP, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HYBRID CLOSED LOOP, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY FLASH GLUCOSE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY FLASH GLUCOSE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INFUSION SETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INFUSION SETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PEN NEEDLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PEN NEEDLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SYRINGE NEEDLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PREFILLED DISPOSABLE PENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PREFILLED DISPOSABLE PENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REUSABLE PENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REUSABLE PENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SMART PENS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SMART PENS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PATCH PUMPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY PATCH PUMPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TUBED PUMPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TUBED PUMPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REAL TIME CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY REAL TIME CONTINUOUS GLUCOSE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RETROSPECTIVE CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RETROSPECTIVE CONTINUOUS GLUCOSE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY FLASH GLUCOSE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY FLASH GLUCOSE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE METERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE METERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LANCETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY TEST STRIPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INTERMITTENT DELIVERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INTERMITTENT DELIVERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INTERMEDIATE ACTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INTERMEDIATE ACTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DETEMIR, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DETEMIR, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLARGINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLARGINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ASPART, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ASPART, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLULISINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GLULISINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LISPRO, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY LISPRO, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SHORT ACTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY SHORT ACTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ULTRA LONG ACTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ULTRA LONG ACTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY ONLINE CHANNELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS DIABETES CARE DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES DIABETES CARE DEVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 215. CANADA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 216. CANADA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 217. CANADA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2024 (USD MILLION)
TABLE 218. CANADA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2025-2030 (USD MILLION)
TABLE 219. CANADA DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 220. CANADA DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 221. CANADA DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2024 (USD MILLION)
TABLE 222. CANADA DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2025-2030 (USD MILLION)
TABLE 223. CANADA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2024 (USD MILLION)
TABLE 224. CANADA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2025-2030 (USD MILLION)
TABLE 225. CANADA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2024 (USD MILLION)
TABLE 226. CANADA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2025-2030 (USD MILLION)
TABLE 227. CANADA DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 228. CANADA DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 229. CANADA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2024 (USD MILLION)
TABLE 230. CANADA DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2025-2030 (USD MILLION)
TABLE 231. CANADA DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2024 (USD MILLION)
TABLE 232. CANADA DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2025-2030 (USD MILLION)
TABLE 233. CANADA DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 234. CANADA DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 235. CANADA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
TABLE 236. CANADA DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
TABLE 237. CANADA DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2024 (USD MILLION)
TABLE 238. CANADA DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2025-2030 (USD MILLION)
TABLE 239. CANADA DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2024 (USD MILLION)
TABLE 240. CANADA DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2025-2030 (USD MILLION)
TABLE 241. CANADA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. CANADA DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. CANADA DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 244. CANADA DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 245. CANADA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. CANADA DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. CANADA DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 248. CANADA DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 249. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 250. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 251. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2024 (USD MILLION)
TABLE 252. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2025-2030 (USD MILLION)
TABLE 253. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 254. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 255. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2024 (USD MILLION)
TABLE 256. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2025-2030 (USD MILLION)
TABLE 257. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2024 (USD MILLION)
TABLE 258. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2025-2030 (USD MILLION)
TABLE 259. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2024 (USD MILLION)
TABLE 260. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2025-2030 (USD MILLION)
TABLE 261. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 262. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 263. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2024 (USD MILLION)
TABLE 264. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2025-2030 (USD MILLION)
TABLE 265. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2024 (USD MILLION)
TABLE 266. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2025-2030 (USD MILLION)
TABLE 267. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 268. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 269. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
TABLE 270. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
TABLE 271. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2024 (USD MILLION)
TABLE 272. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2025-2030 (USD MILLION)
TABLE 273. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2024 (USD MILLION)
TABLE 274. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2025-2030 (USD MILLION)
TABLE 275. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 276. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 277. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 278. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 279. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 280. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 281. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 282. MEXICO DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY GLUCOSE MONITORING DEVICES, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY INJECTION AIDS, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PENS, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN PUMPS, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY SELF MONITORING BLOOD GLUCOSE, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY LONG ACTING, 2025-2030 (USD MILLION)
TABLE 307. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2018-2024 (USD MILLION)
TABLE 308. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY RAPID ACTING, 2025-2030 (USD MILLION)
TABLE 309. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 312. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 313. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2024 (USD MILLION)
TABLE 316. BRAZIL DIABETES CARE DEVICES MARKET SIZE, BY HOSPITALS AND CLINICS, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY DEVICE TYPE, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA DIABETES CARE DEVICES MARKET SIZE, BY ARTIFICIAL PANCREAS SYSTEMS, 2025-2030 (USD M

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • Medtronic plc
  • Roche Holding AG
  • Dexcom, Inc.
  • Becton, Dickinson and Company
  • Insulet Corporation
  • Tandem Diabetes Care, Inc.
  • Terumo Corporation
  • Kyowa Kirin Co., Ltd.
  • Ypsomed Holding AG

Table Information